Cargando…
Retracted: MiR-1270 Suppresses the Malignant Progression of Breast Cancer via Targeting MMD2
Autor principal: | Healthcare Engineering, Journal of |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10412138/ https://www.ncbi.nlm.nih.gov/pubmed/37564800 http://dx.doi.org/10.1155/2023/9843621 |
Ejemplares similares
-
MiR-1270 Suppresses the Malignant Progression of Breast Cancer via Targeting MMD2
por: Hu, Shaojun, et al.
Publicado: (2022) -
Retracted: miR-206 Targets MALAT1 to Suppress Cell Progression of Ectopic Endometrial Stromal Cells in Endometriosis
por: Healthcare Engineering, Journal of
Publicado: (2023) -
Retracted: Clinical Potential of miR-451 and miR-506 as a Prognostic Biomarker in Patients with Breast Cancer
por: Healthcare Engineering, Journal of
Publicado: (2023) -
Retracted: Analysis on Value of Applying Serum miR-144 and miR-221 Levels in Diagnosing Atherosclerosis
por: Engineering, Journal of Healthcare
Publicado: (2023) -
Retracted: The Value of Serum Exosomal miR-184 in the Diagnosis of NSCLC
por: Healthcare Engineering, Journal of
Publicado: (2023)